FundedIQ
Artificial Intelligence

Infinimmune: Funding, Investors & Team (Oct 2026)

Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology.

www.infinimmune.com LinkedIn Alameda, United States 1-10 employees Founded 2022
Total raised
$75.0M
Rounds
1
Latest
Series A
Aug 2026

Infinimmune has raised $75.0M across 1 funding round on record, the most recent a Series A of $75.0M announced in Aug 2026.

That round is above the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.

Infinimmune Company Profile and Key Stats

Total funding raised
$75.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$75.0M in Aug 2026
Employees
1-10
reported band
Founded
2022
Headquarters
Alameda, United States
Investors on record
18
5 named below

Latest funding round on record: Aug 2026.

Infinimmune Funding Rounds

Date
Round
Amount
Series A
$75.0M

Infinimmune Investors

RA Capital Management Pear VC Playground Global Goldcrest Capital Civilization Ventures

18 investors are recorded in total; the 5 named above are those the record identifies.

Infinimmune Founders and Leadership Team

Name
Role
Contact
Wyatt McDonnell
Co-Founder and CEO
Locked
Michael Gibbons
Co-Founder
Locked

Contact details for the Infinimmune team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Infinimmune Funding in Context

Segment
Companies
Median round
30,234
$7.6M
8,558
$15M

Infinimmune's latest round of $75.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Infinimmune in Artificial Intelligence and Alameda

Companies Similar to Infinimmune

Onyx is a research collective building a virtual immune system from longitudinal human immune data.

Undisclosed round $8.0M

Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…

Seed $60.0M

Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…

Seed $11.0M

PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…

Seed $50k

Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…

Seed $3.1M

Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…

Seed $750k

Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…

Seed $3.0M

Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…

Undisclosed round $16.2M

Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…

Seed $700k

Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…

Convertible Note $100k

Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…

Series A $50.0M

Voltus represents the "potential of us" to better manage energy through simple, cost and risk-free…

Series D $225M

Infinimmune Funding FAQs

What does Infinimmune do?

Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology.

How much funding has Infinimmune raised?

Infinimmune has raised $75.0M across 1 round on record. The most recent is a Series A of $75.0M announced in Aug 2026.

When did Infinimmune last raise funding?

Infinimmune's most recent funding round on record is a Series A of $75.0M, announced in Aug 2026.

Who has invested in Infinimmune?

Investors on record for Infinimmune include RA Capital Management, Pear VC, Playground Global, Goldcrest Capital, Civilization Ventures. FundedIQ records 18 investors in total.

Who founded Infinimmune?

FundedIQ lists Wyatt McDonnell (Co-Founder and CEO), Michael Gibbons (Co-Founder) at Infinimmune.

Where is Infinimmune headquartered?

Infinimmune is based in Alameda, United States.

How many employees does Infinimmune have?

Infinimmune is in the 1-10 employee band.

When was Infinimmune founded?

Infinimmune was founded in 2022.

About FundedIQ's Infinimmune Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Infinimmune is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.